NCT02700412View on ClinicalTrials.gov

University of Alabama at Birmingham (UAB) Adult CBD Program

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

August 8, 2019

Study Completion Date

August 8, 2019

Conditions
EpilepsySeizures
Interventions
DRUG

Epidiolex

Epidiolex oral solution (100 mg/mL CBD concentration) with inactive ingredients including anhydrous ethanol, sesame seed oil, strawberry flavor, and sucralose).

Trial Locations (1)

35294

University of Alabama at Birmingham, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER

NCT02700412 - University of Alabama at Birmingham (UAB) Adult CBD Program | Biotech Hunter | Biotech Hunter